Dr. Zook — Curriculum Vitae

EDUCATION

1995-1999
Doctor of Medicine, University of Washington School of Medicine Graduated with Honors

1989-1993
Bachelor of Arts, Cornell UniversityCollege of Arts and Sciences
Major: Psychology, Graduated with Distinction in All Subjects

Spring 1992
Semester abroad, Universidad de Sevilla, Seville, Spain

POSTGRADUATE TRAINING

2005
Fellow, Vulvar Dermatology, Women’s Dermatologic Society

2004-2005
Senior Research Fellow (Funded by NIH Training Grant)

Conducted research in genotype-phenotype correlation in neurofibromatosis-1, under the guidance of Virginia Sybert, M.D. and Karen Stephens, PhD.

2002-2005
Resident Physician, Dermatology, University of Washington, Seattle WA

2000-2001
Dermatology Research Fellow, University of Washington, Seattle WA

Conducted independent research studying non-healing diabetic ulcers in a diabetic mouse model. Defined experimental design, coordinated personnel needed to conduct the study, and analyzed data.

1999-2000
Internship, Obstetrics and Gynecology, University of Washington, Seattle

EMPLOYMENT

2013-2017
Dermatologist, Private Practice, Dermatology Associates, Seattle, WA

2006-2013
Staff Physician and Managing Partner, Dermatology, Polyclinic, Seattle, WA

FACULTY APPOINTMENT

2009-Present
Assistant Clinical Professor, Dermatology, University of Washington

2005-2009
Clinical Instructor, University of Washington, Seattle, WA

VOLUNTEER SERVICE

2014-2016
Delegate, Washington State Medical Association

2013-Present
Trustee, King County Medical Society Board of Trustees

2002-2004
Resident Member, House Staff Association, University of Washington
Elected by peers to represent the house staff in decisions impacting compensation, working conditions, and social functions.

June 2004
Volunteer Medical Staff, Camp Discovery, Minnesota
Provided medical care and companionship for 40 teenagers with serious, disabling skin disease during an American Academy of Dermatology-sponsored summer camp.

2002-2004
Resident Member, House Staff Association, University of Washington
Elected by peers to represent the house staff in decisions impacting compensation, working conditions, and social functions.

BOARD CERTIFICATION

American Board of Dermatology, 2005; Recertified in 2015.

PROFESSIONAL MEMBERSHIPS

King County Medical Society
Washington State Medical Association
American Academy of Dermatology
American Medical Association
Seattle Dermatologic Society
Women’s Dermatologic Society

PUBLICATIONS

  • Zook PD, Winter TC, Nyberg DA. CT measurement of pelvic iliac angle as a marker for Down syndrome in second trimester fetuses. Radiology 1999; 211(2): 447-451.
  • Zook, Paula D. “Diseases of The Vulva.” Practical Gynecology: A Guide for the Primary Care Physician. Janice Ryden and Paul D. Blumenthal. American College of Physicians, 2009. 393-414

PRESENTATIONS

  • Zook PD, Winter TC, Nyberg DA. CT measurement of pelvic iliac angle as a marker for Down syndrome in second trimester fetuses. Radiologic Society of North America’s 83rd Scientific Assembly and Annual Meeting, Chicago, Illinois, December 1997.
  • Zook PD. Dermatitis Herpetiformis: A Fourth Opinion. Grand Rounds: University of Washington School of Medicine, Department of Medicine, Division of Dermatology, October, 2002
  • Zook PD, Hornung R. Pediatric Pernio: A Series of Three Cases. Grand Rounds: University of Washington School of Medicine, Department of Medicine, Division of Dermatology, March 2003.
  • Zook PD, Hornung R, Argenyi Z. Palmoplantar eccrine hidradenitis induced by cold injury. Society for Pediatric Dermatology, June 2003.
  • Zook PD. Collodion Baby and the Ichthyoses. Grand Rounds: University of Washington School of Medicine, Department of Medicine, Division of Dermatology, January, 2004.
  • Zook PD, Hornung R, Argenyi Z. Palmoplantar eccrine hidradenitis induced by cold injury. American Academy of Dermatology, February 2004.
  • Zook PD. Case Presentations: From Disseminated Histoplasmosis to Ulceroglandular Tularemia. Grand Rounds: University of Washington School of Medicine, Department of Medicine, Division of Dermatology June 2004.

CLINICAL RESEARCH

Study 200583: A Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream Administered Once Daily for the Treatment of Plaque Psoriasis (GlaxoSmithKline)

Study 200704: A Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream Administered Once Daily for the Treatment of Atopic Dermatitis (GlaxoSmithKline)

A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice Daily for 12 Weeks in Subjects with Facial Acne Vulgaris (Cassiopea)

A Double-Blind, Placebo-Controlled, Randomized Study on the Safety and Efficacy of Apremilast in Patients with Moderate to Severe Plaque Psoriasis Involving Palms and/or Soles (Innovaderm)

A Double-Blind, Randomized, Placebo-Controlled, Parallel-Controlled, Two-Center, Phase IIb Clinical Trial to Evaluate the Efficacy and Safety of TC cream in Treating Patients with Psoriasis Vulgaris (PRIG)

A Double-Blind, Randomized, Parallel-Group, Vehicle-Controlled, Multicenter Study to Evaluate the Safety and Bioequivalence of a Generic Pimecrolimus Cream, 1% and Reference Listed Elidel® (Pimecrolimus Cream, 1%) and Compare Both Active Treatments to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis (Symbio)

A Multicenter, Randomized, Double-Blind Study Comparing the Efficacy and Safety of Ixekizumab Dosing Regimens in Patients with Moderate to Severe Plaque Psoriasis (Eli Lilly)

An Open-Label Study Assessing Long-Term Safety of DRM04 in Subjects with Primary Axillary Hyperhidrosis (Dermira)

A Phase 3, Randomized, Double-Blind, Vehicle-Controlled Efficacy and Safety Study of DRM04 in Subjects with Axillary Hyperhidrosis (Dermira)

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Investigating the Efficacy and Safety of Multiple Dupilumab Dose Regimens Administered as Monotherapy for Maintaining Treatment Response in Patients with Atopic Dermatitis (Regeneron)

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety and Efficacy of PF04965843 in Patients with Moderate to Severe Psoriasis (Pfizer)

A Phase 3 Confirmatory Study Investigating the Efficacy and Safety of Dupilumab Monotherapy Administered to Adult Patients with Moderate-to-Severe Atopic Dermatitis (Regeneron)

A Phase 3, Multicenter, Randomized, Double-blind, Placebo and Active Comparator-controlled Study Evaluating the Efficacy and Safety of Guselkumab for the Treatment of Subjects with Moderate to Severe Plaque-type Psoriasis with Randomized Withdrawal and Retreatment VOYAGE 2 (Janssen)

A Randomized, Double-Blind, Placebo-Controlled, Study Investigating Vaccine Responses in Adults with Moderate to Severe Atopic Dermatitis Treated with Dupilumab (Regeneron)

XP-H-093, A Phase 2, Randomized, Double-Blind, Multicenter, Parallel-Group, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dose Levels of XP23829 in Subjects with Moderate-to-Severe Chronic Plaque-Type Psoriasis (Xenoport)

A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-0214 Versus Enbrel® in Subjects With Chronic Plaque Psoriasis (CHS-0214-04) (RaPsOdy) (Coherus)

A 52-week, multicenter, randomized, double-blind study of subcutaneous secukinumab to demonstrate efficacy as assessed by Psoriasis Area and Severity Index at 16 weeks of treatment compared to ustekinumab and to assess long-term safety, tolerability and efficacy in subjects with moderate to severe plaque prosiasis (Novartis)

A Phase 2, Randomized, Double-Blind, Vehicle Controlled, Comparator Study Of The Effect Of DRM04B and DRM04 In Subjects With Axillary Hyperhidrosis (Dermira)

A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis who Achieve Complete Clearance on Biologics (Amgen)

An Open-Label Study of Dupilumab in Patients with Atopic Dermatitis who Participated in Previous Dupilumab Clinical Trials (Regeneron)

A Safety and Efficacy Study to Compare Dapsone Dermal Gel with Vehicle Control in Patients with Acne Vulgaris (Allergan)

A Phase 2, Randomized, Double-Blind, Vehicle Controlled, Dose-Ranging Study of the Effect of DRM04B in Subject With Axillary Hyperhidrosis (Dermira)

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, Pharmacokinetic and Biomarker Profiles of Dupilumab (REGN668_ Administered to Adult Patient with Moderate-to-Severe Atopic Dermatitis (Regeneron)

A Phase 3 Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects with Moderate to Severe Hidradenitis Suppurativa (AbbVie)

A Phase 3 Open-Label Study of the Safety and Efficacy of Adalimumab in Subject with Moderate to Severe Hidradenitis Suppurativa (AbbVie)

Pharmacokinetic Evaluations of Ixekizumab following Subcutaneous Administration Using Prefilled Syringe or Auto Injector in Patient with Moderate-to-Severe Plaque Psoriasis (Lilly)

A Randomized, Vehicle-Controlled, Double-Blind, Parallel Group, Multi-Center Phase III Study to Evaluate the Safety and Efficacy of M518101 in Subjects with Plaque Psoriasis (Maruho)

A Phase 3b, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Double-Dummy, Study of the Efficacy and Safety of Apremilast (CC-10004), Etanercept, and Placebo, in Subjects with Moderate to Severe Plaque Psoriasis (Celgene)

A Phase 3 Study to Evaluate the Efficacy and Safety of Induction and Maintenance Regimens of Brodalumab Compared With Placebo and Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis: AMAGINE-2 (Amgen)

A Multicenter Study with a Randomized, Double-Blind, Placebo=Controlled Induction Dosing Period Followed by a Randomized Maintenance Dosing Period and a Long-Term Extension Period to Evaluate the Efficacy and Safety of LY2439821 in Patients with Moderate-to-Severe Plaque Psoriasis (Lilly)

American Academy of DermatologyAmerican Board of DermatologyAmerican Medical AssociationThe International Society For The Study Of Vulvovaginal DiseaseNational Vulvodynia AssociationWashington Dermatology AssociationWomen's Dermatologic Society
Copyright © 2021 Spectrum Dermatology of Seattle
envelopeenterphone-handsetmapcalendar-fullcar linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram